Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Gainers
Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Aslan Pharmaceuticals Pte. Ltd. (Singapore, SG) Granted U.S. Patent #11,382,903 for Cancer therapy
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6615&f=G&l=50&d=PTXT&p=133&S1=20220712&OS=20220712&RS=20220712
44 Stocks Moving In Thursday’s Mid-Day Session: F-star Therapeutics, Revlon And More
Gainers
Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
ASLAN Pharmaceuticals Initiates Scientific Collaboration To Investigate The Distinct Role Of IL-13 Receptor Signaling In Atopic Dermatitis
role of the IL-13Ra1 subunit, distinct from the role of other pathway components, in Type 2-mediated inflammatory diseases, specifically atopic dermatitis (AD).
The research collaboration will evaluate the role of
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 69 companies set new 52-week lows.
Piper Sandler Maintains Overweight on ASLAN Pharma, Lowers Price Target to $3
Piper Sandler analyst Edward Tenthoff maintains ASLAN Pharma (NASDAQ:ASLN) with a Overweight and lowers the price target from $8 to $3.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
